Swedish Match North America: The First-ever MRTPA Accepted by the US FDA
Synchrogenix was an integral part of the first ever successful Modified Risk Tobacco Product Application (MRTPA). That submission was officially accepted for review by the FDA in July 2014. Information related to the submission is publicly available on the FDA MRTPA website.
Please submit your information here to receive a copy of the case study.